Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

KOL Engagement
Health Outcomes Liaison – Managing Relationships with Payors
The job of a Medical Science Liaison (MSL) comes with an amazing variety of responsibilities. In addition, to building and maintaining relationships with key opinion leaders, MSLs are increasingly tasked… Continue reading →

Read the article
Drug Development KOL Engagement
Clinical Trial Enrollment Challenges
We talk a lot about Medical Science Liaisons (MSLs) and Key Opinion Leaders (KOLs) and their roles and responsibilities. We also dedicated a blog to the emerging role of… Continue reading →

Read the article
KOL Engagement
The Typical Medical Science Liaison
We have been writing about Medical Science Liaisons, their jobs, responsibilities, typical job descriptions, scientific background, challenges – regulatory and otherwise – and rewards, about the key opinion leaders (KOLs)… Continue reading →

Read the article
Artificial Intelligence KOL Engagement
5 Ways Artificial Intelligence Will Benefit Medical Science Liaisons
By now, pretty much everybody agrees that artificial intelligence (AI) will change all of our lives forever. From transportation to quality control, from education to medicine, from entertainment to manufacturing,… Continue reading →

Read the article
Commercialization
The Challenges of Unstructured Healthcare Data
During every patient encounter healthcare providers rely on hundreds of discrete data signals on which they base their decisions in order to provide effective treatment. As care teams assess, diagnose… Continue reading →

Read the article
Commercialization
What’s the Outlook for Medical Device Mergers & Acquisitions?
The medical device industry experienced significant M&A in 2018. High-value deals included Boston Scientific’s $4 billion buyout of BTG (expected to close in a few months), Medtronic’s acquisition of Mazor Robotics for $1.64… Continue reading →

Read the article

«‹14 15 161718 19 20 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕